Generation of large numbers of dendritic cells in a closed system using Cell Factories™

Journal of Immunological Methods

Volumn 264, Issue 1-2, 2002, Pages 135-151

  Tuyaerts, Sandra ^a   Noppe, Sofie M ^a   Corthals, Jurgen ^a   Breckpot, Karine ^a   Heirman, Carlo ^a   De Greef, Catherine ^a   Van Riet, Ivan ^b   Thielemans, Kris ^a  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Cell Factory ; Clinical grade cellular vaccine; Dendritic cells; Immunotherapy

Indexed keywords

DEXTRAN; LATEX; MATRIX PROTEIN;

ADHERENT CELL; ANIMAL CELL; APHERESIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; DEVICE; IMMATURITY; IMMUNOPHENOTYPING; MEMORY CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; TISSUE CULTURE;

ANIMALS; CELL ADHESION; CELL COUNT; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CLONE CELLS; CRYOPRESERVATION; CULTURE TECHNIQUES; DENDRITIC CELLS; ELECTROPORATION; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; MONOCYTES; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; VIRAL MATRIX PROTEINS;

EID: 0036606341     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00099-6     Document Type: Article

References (46)

1. Dendritic cells and the control of immunity
2. Immunobiology of dendritic cells
3. Dendritic cells
4. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
5. Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use
6. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
7. In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy
8. Origin, maturation and antigen presenting function of dendritic cells
9. Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma
10. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment
11. Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: An alternative to standard buffy coats
12. Functional maturation of dendritic cells by exposure to CD40L transgenic tumor cells, fibroblasts or keratinocytes
13. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use
14. Dendritic cells in cancer immunotherapy
15. Dendritic cells injected via different routes induce immunity in cancer patients
16. Immunotherapy of cancer with dendritic-cell-based vaccines
17. A CD1a+/CD11c+subset of human blood dendritic cells is a direct precursor of Langerhans cells
18. Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
19. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA
20. Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuli
21. + cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells
22. + progenitor cells
23. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation
24. RNA-transfected dendritic cells in cancer immunotherapy
25. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy
26. Immunotherapy of cancer with dendritic cell-based vaccines
27. + peripheral blood monocytes
28. MHC class II restricted antigen presentation
29. DNA immunization: Ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction
30. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
31. Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity
32. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
33. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
34. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins
35. Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients
36. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells
37. + blood progenitors for anticancer therapy
38. The dendritic cell system and its role in immunogenicity
39. Identification of CD68+lin - Peripheral blood cells with dendritic precursor characteristics
40. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells
41. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
42. Generation of immature autologous clinical grade dendritic cells for vaccination of cancer patients
43. Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer
44. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: Superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells
45. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily